4133 Stock Overview
Abnova (Taiwan) Corporation manufactures and sells various recombinant proteins and antibodies.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 2/6 |
Financial Health | 5/6 |
Dividends | 1/6 |
Abnova (Taiwan) Corporation Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | NT$32.15 |
52 Week High | NT$38.85 |
52 Week Low | NT$30.95 |
Beta | 0.41 |
1 Month Change | -2.72% |
3 Month Change | -8.40% |
1 Year Change | -12.04% |
3 Year Change | -39.34% |
5 Year Change | 3.71% |
Change since IPO | -39.02% |
Recent News & Updates
Shareholder Returns
4133 | TW Life Sciences | TW Market | |
---|---|---|---|
7D | 1.7% | 1.6% | 1.9% |
1Y | -12.0% | -28.7% | 26.7% |
Return vs Industry: 4133 exceeded the TW Life Sciences industry which returned -28.7% over the past year.
Return vs Market: 4133 underperformed the TW Market which returned 26.7% over the past year.
Price Volatility
4133 volatility | |
---|---|
4133 Average Weekly Movement | 2.5% |
Life Sciences Industry Average Movement | 5.3% |
Market Average Movement | 4.2% |
10% most volatile stocks in TW Market | 8.0% |
10% least volatile stocks in TW Market | 1.9% |
Stable Share Price: 4133 has not had significant price volatility in the past 3 months.
Volatility Over Time: 4133's weekly volatility (3%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
n/a | n/a | n/a | https://www.abnova.com |
Abnova (Taiwan) Corporation manufactures and sells various recombinant proteins and antibodies. The company’s products portfolio includes SARS-CoV/CoV-2, DNA and RNA, proteins/peptides, DNAxPab, lysates/slides, beads/dyes, antibody pairs/kits, antibody and tissue arrays, in situ hybridization products, systems and automations, GMP and analyte specific reagents, and in vitro diagnostics. It also provides MaxPab, monoclonal, polyclonal, recombinant, conjugate, secondary/tag, IHC/pathology, and circulating rare cell antibodies.
Abnova (Taiwan) Corporation Fundamentals Summary
4133 fundamental statistics | |
---|---|
Market cap | NT$1.95b |
Earnings (TTM) | NT$43.68m |
Revenue (TTM) | NT$382.05m |
44.6x
P/E Ratio5.1x
P/S RatioIs 4133 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
4133 income statement (TTM) | |
---|---|
Revenue | NT$382.05m |
Cost of Revenue | NT$208.14m |
Gross Profit | NT$173.92m |
Other Expenses | NT$130.24m |
Earnings | NT$43.68m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | 0.72 |
Gross Margin | 45.52% |
Net Profit Margin | 11.43% |
Debt/Equity Ratio | 0.03% |
How did 4133 perform over the long term?
See historical performance and comparison